Biotech Startups

BE Therapeutics is an early-stage biotech company developing stem cell-derived replacement tissue to repair damage to the brain and spinal cord caused by stroke, trauma, neurodegeneration, and aging. It engineers precursor brain tissue and biomaterials such as its "PiaGel" for pre-clinical and clinical applications in central nervous system repair.

1 investor

Better Dairy uses precision fermentation to produce bioactive milk proteins for applications such as infant formula that more closely mimics breastmilk and supplements aimed at faster workout recovery. The company positions its animal-free proteins as having a lower environmental footprint than conventional dairy.

1 investor

Bexion Pharmaceuticals is a clinical-stage biopharmaceutical company developing biologic cancer therapies that target dysregulated sphingolipid metabolism to counter tumor survival and treatment resistance. Its lead program, BXQ-350, is being studied in patients with advanced solid tumors, including metastatic colorectal cancer.

1 investor

Bifido is a South Korean microbiome company that researches and develops Bifidobacterium strains and pharmabiotics — human microbiome-derived materials intended for the prevention or treatment of disease. It focuses on immune-related conditions such as rheumatoid arthritis and cancer, and produces probiotic strains including FDA-registered ingredients.

1 investor

Bilix develops BRIXELLE-ONCO, a bilirubin nanoparticle technology that serves as a non-toxic drug carrier for anti-cancer agents, designed to reduce side effects in cancer treatment by improving drug delivery to tumor sites. The technology uses naturally occurring bilirubin conjugated with PEG to encapsulate and deliver hydrophobic anti-cancer drugs with minimal systemic toxicity.

1 investor

Bind-X develops biological dust control technology for mining operations, using a natural bio-cementation process to bind soil particles and reduce dust on haul roads, tailings facilities, and stockpiles while significantly lowering water consumption and environmental impact.

1 investor

BIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.

1 investor

Bioplastix engineers E. coli and Halomonas bacteria using AI, enzyme optimization, and precision fermentation to produce high-performance PLA and PHB biopolymers from low-cost sugars and agroindustrial waste. It acts as a technology partner for petrochemical companies, agribusinesses, and consumer goods manufacturers, providing custom microbial strains, biopolymer formulations, and bioprocesses for bioplastic production.

1 investor

Distributor of scientific instrumentation and laboratory consumables serving food and beverage manufacturers, production, and materials science customers across Australia and New Zealand. Offers equipment and services for physical and chemical characterisation, life science, sample preparation, and general lab needs.

1 investor

BioAgilytix provides bioanalytical laboratory services supporting drug development across all phases, from preclinical through clinical studies. The company operates advanced facilities across North America, Europe, and Australia, specializing in large molecule bioanalysis, LC/MS testing, and diagnostic services for the biopharmaceutical industry.

1 investor

BioAlert Solutions develops qPCR-based monitoring systems for detecting Legionella in cooling towers and water systems across North America. The company serves industries, hospitals, and facility managers to enhance public health safety and ensure regulatory compliance.

1 investor

BioAmp Diagnostics develops a chemistry-based rapid diagnostic pipeline (DETECT: Dual-Enzyme Trigger-Enabled Cascade Technology) that delivers infection results in minutes to guide antibiotic prescribing, initially targeting complicated urinary tract infections. The technology is intended to help physicians select the correct antibiotic and support efforts to combat antibiotic resistance.

1 investor

Bioarchitech develops oncolytic virus therapies and RNA-based immunotherapy candidates for cancer treatment. The company combines expertise in viral engineering, immunology, and preclinical development to advance novel therapeutic platforms.

1 investor

BioAscent provides integrated drug discovery services including medicinal chemistry, biosciences, computational discovery, and compound management. The company serves pharmaceutical and biotech clients requiring external research capabilities.

1 investor

BioAtlantis develops bioactive compounds extracted from seaweed and terrestrial resources to mitigate stress in plants, animals, and humans. The company serves the agricultural crop sector with naturally derived biostimulants and nutraceuticals designed to strengthen natural defence systems.

1 investor

Biobase builds data infrastructure to make clinical data accessible across the healthcare value chain, positioning itself as the "rails" for precision medicine rather than a data marketplace. It serves participants in the healthcare and life sciences sector by connecting data generated during care with downstream medicine development.

1 investor

BioBlends develops biopreservation products that use volatile organic compounds from beneficial bacteria, combined with bioinformatics and experimental validation, to control preservative-resistant microorganisms and fungal contamination in food. Its solutions extend shelf life across food matrices without chemical residues, serving industrial food producers such as baked goods manufacturers.

1 investor

Biocare Medical develops automated immunohistochemistry and molecular pathology instrumentation and reagents for tissue diagnostic testing. The company serves clinical and research laboratories, pharmaceutical companies, and biotechnology firms conducting cancer and infectious disease diagnostics.

1 investor

Biocartesian provides optical pooled screening services for functional genomics research. The company uses its proprietary ARADIA technology to link microscopy-based cellular phenotypes with genetic perturbations, enabling researchers to conduct large-scale CRISPR screens and other genomic studies with visual, spatial, and live-cell readouts.

1 investor

BioCell Analytica provides effect-based analysis using cultured cells to detect health- and environment-hazardous contaminants in water, soil, and sediment, capturing the combined "cocktail effect" of multiple substances. It serves the water industry for testing drinking water, wastewater treatment efficiency, and chemical pollution monitoring.

1 investor

Biocellis develops a patented bioluminescence immunoassay platform that delivers laboratory-grade, picogram-level sensitivity with results in under 60 seconds in a compact, portable format for point-of-care and high-throughput screening. Its diagnostics target human health, veterinary, environmental, food safety, and public screening applications across hospitals, clinics, and field settings.</parameter> <parameter name="founders">[{"full_name": "Vincent Poher", "title": "Co-founder", "linkedin_url": "https://www.linkedin.com/in/vincentpoher/"}, {"full_name": "Thierry Rose", "title": "Co-founder", "linkedin_url": "https://www.linkedin.com/in/thierry-rose-122013254/"}, {"full_name": "Sophie Goyard", "title": "Co-founder", "linkedin_url": "https://www.linkedin.com/in/sophie-goyard-968844103/"}]</parameter> <parameter name="hq_city">Grenoble

1 investor

Bioceres Crops develops and commercializes agricultural productivity solutions—including patented seed technologies (such as its HB4 drought-tolerant program), microbial ag-inputs, crop nutrition and protection products, and digital tools for growers. It serves farmers and agricultural stakeholders with technologies aimed at improving crop resilience to climate change and enabling production traceability.

1 investor

BioChange develops CellFoam, a biodegradable and biocompatible foam scaffold technology for regenerative medicine that supports tissue repair and organ recovery. Its product lines target dental, aesthetic, and human medical uses as well as veterinary care (including products like ReFoam, Revolette, ReGumVet, VetFoam, and vitaloc), with its veterinary line already in the U.S. market.

1 investor

BioChip Labs provides laboratory testing services for blood disorders, including sickle cell disease and thalassemia, using traditional and proprietary blood cell analysis methods. The company conducts comprehensive biomarker assays and works with clinicians and researchers.

1 investor